Novo Nordisk Aktie
64,08
EUR
-1,30
EUR
-1,99
%
60,86
CHF
-0,68
CHF
-1,11
%
Werbung
Novo Nordisk Aktie Analyse
04.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
03.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
29.04.22 | Novo Nordisk Outperform | Bernstein Research | |
29.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
21.04.22 | Novo Nordisk Outperform | Bernstein Research | |
12.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
01.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
16.03.22 | Novo Nordisk Buy | Deutsche Bank AG | |
Werbung
|
|||
04.03.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
15.02.22 | Novo Nordisk Overweight | Barclays Capital | |
03.02.22 | Novo Nordisk Outperform | Bernstein Research | |
02.02.22 | Novo Nordisk Outperform | Bernstein Research | |
02.02.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
31.01.22 | Novo Nordisk Overweight | Barclays Capital | |
26.01.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
24.01.22 | Novo Nordisk Outperform | Bernstein Research | |
04.01.22 | Novo Nordisk Outperform | Bernstein Research | |
21.12.21 | Novo Nordisk Overweight | Barclays Capital | |
07.12.21 | Novo Nordisk Buy | Deutsche Bank AG | |
29.11.21 | Novo Nordisk Buy | Deutsche Bank AG | |
26.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
26.11.21 | Novo Nordisk Outperform | Bernstein Research | |
22.11.21 | Novo Nordisk Overweight | Barclays Capital | |
18.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.11.21 | Novo Nordisk Overweight | Barclays Capital | |
04.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
03.11.21 | Novo Nordisk Outperform | Bernstein Research | |
03.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
01.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
29.10.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
27.10.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
18.10.21 | Novo Nordisk Overweight | Barclays Capital | |
14.10.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
28.09.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
01.09.21 | Novo Nordisk Buy | Deutsche Bank AG | |
20.08.21 | Novo Nordisk Outperform | Bernstein Research | |
17.08.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
06.08.21 | Novo Nordisk Buy | Deutsche Bank AG | |
06.08.21 | Novo Nordisk Outperform | Bernstein Research | |
05.08.21 | Novo Nordisk Overweight | Barclays Capital | |
05.08.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
04.08.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.08.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
29.07.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
19.07.21 | Novo Nordisk Overweight | Barclays Capital | |
07.07.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
30.06.21 | Novo Nordisk buy | Deutsche Bank AG | |
28.06.21 | Novo Nordisk overweight | JP Morgan Chase & Co. |
Werbung
Werbung